4.6 Article

Comparison of Endothelial Keratoplasty Techniques in Patients With Prior Glaucoma Surgery: A Case-Matched Study

期刊

AMERICAN JOURNAL OF OPHTHALMOLOGY
卷 206, 期 -, 页码 94-101

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2019.03.020

关键词

-

资金

  1. Research to Prevent Blindness, New York City, New York
  2. National Eye Institute (Bethesda, Maryland) [RO1 EY021797, RO1 EY028557]
  3. California Institute for Regenerative Medicine (Oakland, California) [TR2 TR2-01768, CLIN1-08686]
  4. National Eye Institute, the Eye Bank Association of America (Washington, DC)
  5. Research to Prevent Blindness
  6. Aerie Pharmaceuticals (Durham, North Carolina)
  7. Allergan (Dublin, Ireland)
  8. Alcon (Elkridge, Maryland)
  9. New World Medical, Inc (Rancho Cucamonga, California)
  10. Glaukos Ltd (San Clemente, California)
  11. Unity Biotechnology (San Francisco, California)
  12. WL Gore and Associates (Newark, Delaware)

向作者/读者索取更多资源

PURPOSE: To compare the outcomes of Descemet membrane endothelial keratoplasty (DMEK) with those of Descemet's stripping endothelial keratoplasty (DSEK) in eyes with prior glaucoma surgery. DESIGN: Case-matched retrospective comparative case series. METHODS: Setting/study population: 46 DMEK procedures were matched with 46 DSEK procedures at a single institution. Observation procedures: cases were matched based on preoperative visual acuity, lens status, and surgical indication. Main outcome measurements: the outcome measurements included visual acuity improvement, primary and secondary graft failure, endothelial rejection, intraocular pressure (IOP) elevation, and the need for additional glaucoma intervention. RESULTS: Best-corrected visual acuity (BCVA) improved by - 0.89 logMAR in the DMEK group and -0.62 logMAR in the DSEK group (P = 0.005) at 1 year follow-up. Visual acuity was significantly better in the DMEK group at postoperative months 1, 3, and 12 and at last follow-up. The percentage of patients achieving 20/40 or better best-corrected visual acuity was higher in the DMEK group at all time points, notably 47% in the DMEK group versus 15% in the DSEK group at 1 year (P = 0.002). Secondary graft failure was lower in the DMEK group (DMEK 0% vs. DSEK 17%; P = 0.006). Primary graft failure rates and rebubling rates were similar. There were no differences in the rates of postoperative IOP elevation or in the need for additional glaucoma intervention. CONCLUSIONS: In complex eyes with prior glaucoma surgery, DMEK offers faster visual recovery, better final visual acuity, and a lower rate of secondary graft failure compared to DSEK during the first postoperative year and beyond. (C) 2019 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据